What is Homocysteine and Why Men Should Care About It.
Homocysteine is a natural compound your body makes when it breaks down protein. It’s part of a process called the methylation cycle, which helps your body repair cells, make energy, and control inflammation.
Normally, homocysteine gets recycled or turned into another compound called cysteine, which helps produce glutathione — one of your body’s main antioxidants that protects your cells from damage (Selhub, 1999).
To keep this process running smoothly, your body needs enough vitamins B6, B12, and folate, along with key enzymes like MTHFR that help move everything along (Refsum et al., 1998).
When Homocysteine Gets Too High
Elevated homocysteine — known as hyperhomocysteinemia — has been linked to a long list of chronic diseases. High levels can damage the endothelium (the inner lining of blood vessels), increase oxidative stress, reduce nitric oxide availability, and promote inflammation — all of which accelerate atherosclerosis and cardiovascular disease (Refsum et al., 1998; Humphrey et al., 2008).
Research also connects elevated homocysteine to an increased risk of stroke, dementia, and Alzheimer’s disease, likely due to impaired blood flow and neurotoxic effects in the brain (Smith & Refsum, 2016). It may even contribute to osteoporosis by interfering with collagen cross-linking in bone (van Meurs et al., 2004), and to pregnancy complications such as preeclampsia or neural tube defects (Mills et al., 1995).
Common causes of high homocysteine include deficiencies in folate, B6, or B12, chronic kidney disease, hypothyroidism, excessive alcohol or caffeine intake, smoking, and certain genetic variants like MTHFR C677T (Clarke et al., 1991).
When It’s Too Low
Low homocysteine levels are rare but can signal an imbalance in the opposite direction. Extremely low values (below ~4 µmol/L) can suggest over-methylation or excessive clearance, which may limit cysteine and glutathione production — both vital for detoxification and antioxidant defense (Pizzorno, 2014). In these cases, the issue may stem from low dietary protein or methionine intake rather than B-vitamin deficiency.
Normal vs Optimal Ranges
Most labs define a “normal” homocysteine level as anything below 15 µmol/L. However, research consistently shows that cardiovascular risk begins to climb above 10 µmol/L (Refsum et al., 1998; Wald et al., 2002).
5–8 µmol/L to be the optimal range, reflecting efficient methylation and low oxidative stress (Pizzorno, 2014). On the other hand, levels below 4 µmol/L may indicate reduced methylation throughput or inadequate methionine supply.
Supplementation and Lifestyle Support
The most effective way to manage homocysteine is through nutrient optimization:
Folate (B9): Prefer methyl-folate (5-MTHF) or folinic acid instead of folic acid, as these are bioactive forms not dependent on MTHFR conversion (Selhub, 1999).
Vitamin B12: Use methylcobalamin or adenosylcobalamin, especially in vegans or older adults with low absorption (Clarke et al., 1991).
Vitamin B6 (pyridoxal-5-phosphate): Supports the transsulfuration pathway converting homocysteine into cysteine (Pizzorno, 2014).
Betaine (trimethylglycine): Donates methyl groups to recycle homocysteine back to methionine (Olthof et al., 2003).
Riboflavin (B2): Particularly important in people with MTHFR variants (McNulty et al., 2006).
Large-scale clinical trials show that B-vitamin supplementation reliably lowers homocysteine but may not always translate into fewer cardiovascular events — highlighting that homocysteine is a marker, not necessarily the cause (Bønaa et al., 2006). Still, keeping it in the optimal zone likely supports long-term vascular and neurological health.
Lifestyle factors also matter: quit smoking, limit alcohol, eat more leafy greens and legumes, and manage kidney and thyroid function — all of which help maintain balance (Smith & Refsum, 2016).
Conclusion
Homocysteine is more than a lab number — it’s a metabolic signal reflecting your body’s nutritional, vascular, and detoxification status. Both high and low levels can spell trouble. Aim for the optimal zone (5–8 µmol/L), ensure sufficient B-vitamin intake, and revisit your results periodically. Managing homocysteine is less about chasing a number and more about keeping the entire methylation system working efficiently.
If you want to start managing your health and training better, join The Forge or reach out to me directly at jackson@drjacksontaylor.com.
The Dear Brothers Podcast — Weekly conversations on strength, faith, and the pursuit of better manhood. Available on all major platforms.
Proud Ambassador for The Vintage Gentlemen — Makers of timeless gear for the modern man. From handcrafted leather goods to whiskey decanters, they embody craftsmanship and character.
Use code DRJACKSON20 for 20% off your order at thevintagegentlemen.com.
Follow Along — Instagram: @drjacksontaylor
Books & Courses — For more ebooks & courses, please join The Brotherhood.
References:
Bønaa, K.H. et al. (2006) ‘Homocysteine lowering and cardiovascular events after acute myocardial infarction’, New England Journal of Medicine, 354(15), pp. 1578–1588.
Clarke, R. et al. (1991) ‘Hyperhomocysteinemia: an independent risk factor for vascular disease’, New England Journal of Medicine, 324(17), pp. 1149–1155.
Humphrey, L.L., Fu, R., Rogers, K., Freeman, M. and Helfand, M. (2008) ‘Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis’, Mayo Clinic Proceedings, 83(11), pp. 1203–1212.
McNulty, H. et al. (2006) ‘Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the MTHFR 677C→T polymorphism’, Hypertension, 48(4), pp. 846–852.
Mills, J.L. et al. (1995) ‘Homocysteine metabolism in pregnancies complicated by preeclampsia’, American Journal of Obstetrics and Gynecology, 173(5), pp. 1479–1485.
Olthof, M.R., van Vliet, T., Verhoef, P. and Zock, P.L. (2003) ‘Effect of betaine supplementation on plasma homocysteine concentrations in healthy adults’, American Journal of Clinical Nutrition, 78(4), pp. 761–767.
Pizzorno, J. (2014) ‘Homocysteine: friend or foe?’, Integrative Medicine: A Clinician’s Journal, 13(4), pp. 8–10.
Refsum, H. et al. (1998) ‘Homocysteine and cardiovascular disease’, Annual Review of Medicine, 49, pp. 31–62.
Selhub, J. (1999) ‘Homocysteine metabolism’, Annual Review of Nutrition, 19, pp. 217–246.
Smith, A.D. and Refsum, H. (2016) ‘Homocysteine, B vitamins, and cognitive impairment’, Annual Review of Nutrition, 36, pp. 211–239.
van Meurs, J.B. et al. (2004) ‘Homocysteine levels and the risk of osteoporotic fracture’, New England Journal of Medicine, 350(20), pp. 2033–2041.
Wald, D.S., Law, M. and Morris, J.K. (2002) ‘Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis’, BMJ, 325(7374), pp. 1202–1206.
